olmesartan has been researched along with methylprednisolone in 2 studies
Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (methylprednisolone) | Trials (methylprednisolone) | Recent Studies (post-2010) (methylprednisolone) |
---|---|---|---|---|---|
841 | 185 | 554 | 20,247 | 2,602 | 5,317 |
Protein | Taxonomy | olmesartan (IC50) | methylprednisolone (IC50) |
---|---|---|---|
Glucocorticoid receptor | Homo sapiens (human) | 0.011 | |
Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.011 | |
Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.011 | |
Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.011 | |
Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.011 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Bi, X; Shan, L; Wang, S; Zhou, Y | 1 |
2 other study(ies) available for olmesartan and methylprednisolone
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Orolingual angioedema associated with olmesartan use after recombinant tissue plasminogen activator treatment of acute stroke.
Topics: Acute Disease; Aged, 80 and over; Angioedema; Antihypertensive Agents; Female; Humans; Imidazoles; Lip; Methylprednisolone; Recombinant Proteins; Stroke; Tetrazoles; Tissue Plasminogen Activator; Tongue; Uvula | 2014 |